Interleukin-37 protects against acinar cell pyroptosis in acute pancreatitis

Acute pancreatitis (AP) is a local and/or systemic inflammatory disease that starts with acinar cell injury and necrosis; it has no effective medical treatment and thus remains a lifethreatening condition. Interleukin-37 (IL-37), a natural immunomodulator, has demonstrated an antiinflammatory effect; however, the role of IL-37 in AP remains unknown. The serum IL-37 levels of 39 healthy controls and 94 patients with AP were measured. Cholecystokinin was applied to induce pancreatic acinar cell injury in vitro. Classical experimental AP models, such as caerulein, l-arginine, and taurolithocholic acid 3-sulfate disodium salt, were included in the in vivo study. A transgenic mouse model with the IL-37 gene and administration of recombinant ILresults showed that serum IL-37 levels in humans were negatively correlated with the severity of protect against AP. Mechanistically, IL-37 was able to suppress pyroptosis of injured acinar cells, study demonstrates that IL-37 protects against acinar cell pyroptosis in AP.

Automated summary

Acute pancreatitis is an inflammatory disease with no effective medical treatment. IL-37 has anti-inflammatory effects and can protect pancreatic cells from death.